Blog Collection

Blog Hero Image

THE FDA HEARD US LOUD AND CLEAR!

On September 11, the FDA held a half-day patient-focused drug development (PFDD) meeting focused exclusively on alopecia areata. The goal was to collect patient perspectives on current and potential treatment options and learn about the ways alopecia areata impacts our everyday lives. A resounding theme was the need for effective therapeutic options for all age groups with the disease. Learn More